SCHEMBL20816552

SCHEMBL20816552

CC(NC(=O)C(Cc1ccccc1)NC(=O)Cc1ccccc1)C(=O)C(=O)NC(Cc1ccc(C(C)(C)C)cc1)C(=O)NC(C)(C)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 5/20 0.47
▸ CTSL P07711 2/20 0.46
▸ CTSB P07858 1/20 0.46
▸ CTSS P25774 1/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ CHRNA1 P02708 3/20 0.42
▸ CHRNG P07510 3/20 0.42
▸ CHRNB1 P11230 3/20 0.42
▸ CHRND Q07001 3/20 0.42
▸ MMP9 P14780 1/20 0.41
▸ MMP8 P22894 1/20 0.41
▸ MMP14 P50281 1/20 0.41
▸ PTPN2 P17706 2/20 0.40
▸ GRIA1 P42261 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ PTPRA P18433 1/20 0.40
▸ PTPN6 P29350 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20816661 1.00 PTPN1 (0.47) PTPN1CTSLCTSBCTSSALDH1A1
SCHEMBL20816657 0.94 CTSL (0.51) PTPN1CTSLCTSBCTSSALDH1A1
SCHEMBL20816660 0.94 CTSL (0.51) PTPN1CTSLCTSBCTSSALDH1A1
SCHEMBL20816609 0.90 PTPN1 (0.43) PTPN1CTSLCTSBCTSSALDH1A1
SCHEMBL20827936 0.90 PTPN1 (0.43) PTPN1CTSLCTSBCTSSALDH1A1
SCHEMBL20816930 0.90 PTPN1 (0.43) PTPN1CTSLCTSBCTSSALDH1A1
SCHEMBL20816735 0.90 MMP9 (0.51) PTPN1CTSLCTSBCTSSMMP9
SCHEMBL20816915 0.90 MMP9 (0.51) PTPN1CTSLCTSBCTSSMMP9
SCHEMBL20816766 0.88 PTPN1 (0.62) PTPN1CTSLCTSBCTSSALDH1A1
SCHEMBL20816767 0.88 PTPN1 (0.62) PTPN1CTSLCTSBCTSSALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190085024-A1 Alpha-Ketoamide Inhibitors Of Cysteine Proteases Phelix Therapeutics (US) 2019-03-21 — — US claimed
US-20190085024-A1 Alpha-Ketoamide Inhibitors Of Cysteine Proteases Phelix Therapeutics (US) 2019-03-21 — — US disclosed
US-20190085024-A1 Alpha-Ketoamide Inhibitors Of Cysteine Proteases Phelix Therapeutics (US) 2019-03-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190085024-A1 Alpha-Ketoamide Inhibitors Of Cysteine Proteases CTSS, CTSB, CTSL PTPN1 4631/4885CTSL 3/4885CTSB 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback